USI CORPORATION |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 15.75 TWD | -0.63% |
|
-4.26% | -20.25% |
| Apr. 25 | USI's Q1 Profit Rises 21%, Operating Income Jumps 4% | MT |
| Mar. 15 | USI Corporation Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Summary
- Overall, and from a short-term perspective, the company presents an interesting fundamental situation.
Strengths
- The company is one of the most undervalued, with an "enterprise value to sales" ratio at 0.39 for the 2024 fiscal year.
- The company appears to be poorly valued given its net asset value.
- Historically, the company has been releasing figures that are above expectations.
Weaknesses
- As estimated by analysts, this group is among those businesses with the lowest growth prospects.
- As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
- The company has insufficient levels of profitability.
- For the last twelve months, sales expectations have been significantly downgraded, which means that less important sales volumes are expected for the current fiscal year over the previous period.
- Revenue estimates are regularly revised downwards for the current and coming years.
- For the past year, analysts have significantly revised downwards their profit estimates.
- Over the past four months, analysts' average price target has been revised downwards significantly.
- Over the past twelve months, analysts' opinions have been revised negatively.
Ratings chart - Surperformance
Sector: Commodity Chemicals
| 1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
|---|---|---|---|---|
| -20.25% | 527M | - | ||
| +5.32% | 40.03B | B- | ||
| -21.04% | 21.8B | B- | ||
| -16.29% | 13.22B | B- | ||
| -13.00% | 9.94B | B+ | ||
| -7.16% | 9.76B | A- | ||
| +20.46% | 8.41B | C+ | ||
| +7.95% | 6.88B | C+ | ||
| -30.48% | 5.32B | C | ||
| -24.80% | 3.65B | B+ |
Investor Rating
Trading Rating
ESG Refinitiv
-
Financials
Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances
Valuation
P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-
Momentum
1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision
Consensus
Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
-
12m Revision of opinion
Business Predictability
Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
Divergence of Target Price
Earnings quality
Technical analysis
ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
- Stock Market
- Equities
- 1304 Stock
- Ratings USI Corporation
